Loading...

Masimo Corporation

0JZ2.LLSE
Healthcare
Medical - Equipment & Services
£161.59
£7.53(4.89%)

Masimo Corporation (0JZ2.L) Financial Performance & Income Statement Overview

Review Masimo Corporation (0JZ2.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
2.26%
2.26%
Operating Income Growth
-295.38%
295.38%
Net Income Growth
-474.11%
474.11%
Operating Cash Flow Growth
108.71%
108.71%
Operating Margin
-11.28%
11.28%
Gross Margin
50.50%
50.50%
Net Profit Margin
-25.06%
25.06%
ROE
-40.95%
40.95%
ROIC
-12.74%
12.74%

Masimo Corporation (0JZ2.L) Income Statement & Financial Overview

Analyze Masimo Corporation’s 0JZ2.L earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$372.00M$600.70M$504.60M$496.30M
Cost of Revenue$138.00M$356.00M$241.40M$241.50M
Gross Profit$234.00M$244.70M$263.20M$254.80M
Gross Profit Ratio$0.63$0.41$0.52$0.51
R&D Expenses$33.90M$77.70M$48.30M$49.00M
SG&A Expenses$119.40M$221.60M$184.80M$177.50M
Operating Expenses$156.00M$603.80M$233.10M$226.50M
Total Costs & Expenses$294.00M$655.30M$474.50M$468.00M
Interest Income$1.40M$1.10M$1.30M$1.20M
Interest Expense$8.80M$10.00M$10.50M$11.00M
Depreciation & Amortization$8.60M$30.80M$24.00M$23.90M
EBITDA$85.80M-$320.90M$46.10M$52.20M
EBITDA Ratio$0.23-$0.53$0.09$0.11
Operating Income$78.00M-$359.00M$30.10M$28.30M
Operating Income Ratio$0.21-$0.60$0.06$0.06
Other Income/Expenses (Net)-$9.60M-$2.70M-$18.50M-$8.40M
Income Before Tax$68.40M-$361.70M$11.60M$19.90M
Income Before Tax Ratio$0.18-$0.60$0.02$0.04
Income Tax Expense$21.20M-$12.10M$1.80M$3.90M
Net Income-$170.70M-$349.60M$9.80M$16.00M
Net Income Ratio-$0.46-$0.58$0.02$0.03
EPS-$3.17-$6.52$0.18$0.30
Diluted EPS-$3.17-$6.52$0.18$0.29
Weighted Avg Shares Outstanding$54.00M$53.60M$53.40M$53.10M
Weighted Avg Shares Outstanding (Diluted)$54.80M$53.60M$54.30M$54.30M

Over the last four quarters, Masimo Corporation's revenue moved from $496.30M in Q2 2024 to $372.00M in Q1 2025. Operating income in Q1 2025 was $78.00M, with a strong operating margin of 21%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Masimo Corporation remained robust at $85.80M, reflecting operational efficiency. Net income rose to -$170.70M, with an EPS of -$3.17. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;